A membrane-associated MHC-I inhibitory axis for cancer immune evasion

Xufeng Chen, Qiao Lu, Hua Zhou, Jia Liu, Bettina Nadorp, Audrey Lasry, Zhengxi Sun, Baoling Lai, Gergely Rona, Jiangyan Zhang, Michael Cammer, Kun Wang, Wafa Al-Santli, Zoe Ciantra, Qianjin Guo, Jia You, Debrup Sengupta, Ahmad Boukhris, Hongbing Zhang, Cheng LiuPeter Cresswell, Patricia L.M. Dahia, Michele Pagano, Iannis Aifantis, Jun Wang

Producción científica: Articlerevisión exhaustiva

22 Citas (Scopus)

Resumen

Immune-checkpoint blockade has revolutionized cancer treatment, but some cancers, such as acute myeloid leukemia (AML), do not respond or develop resistance. A potential mode of resistance is immune evasion of T cell immunity involving aberrant major histocompatibility complex class I (MHC-I) antigen presentation (AP). To map such mechanisms of resistance, we identified key MHC-I regulators using specific peptide-MHC-I-guided CRISPR-Cas9 screens in AML. The top-ranked negative regulators were surface protein sushi domain containing 6 (SUSD6), transmembrane protein 127 (TMEM127), and the E3 ubiquitin ligase WWP2. SUSD6 is abundantly expressed in AML and multiple solid cancers, and its ablation enhanced MHC-I AP and reduced tumor growth in a CD8+ T cell-dependent manner. Mechanistically, SUSD6 forms a trimolecular complex with TMEM127 and MHC-I, which recruits WWP2 for MHC-I ubiquitination and lysosomal degradation. Together with the SUSD6/TMEM127/WWP2 gene signature, which negatively correlates with cancer survival, our findings define a membrane-associated MHC-I inhibitory axis as a potential therapeutic target for both leukemia and solid cancers.

Idioma originalEnglish (US)
Páginas (desde-hasta)3903-3920.e21
PublicaciónCell
Volumen186
N.º18
DOI
EstadoPublished - ago 31 2023

ASJC Scopus subject areas

  • General Biochemistry, Genetics and Molecular Biology

Huella

Profundice en los temas de investigación de 'A membrane-associated MHC-I inhibitory axis for cancer immune evasion'. En conjunto forman una huella única.

Citar esto